CA3215826A1 - Use of chlorophyll derivatives for the treatment of sars-cov-2 infection - Google Patents
Use of chlorophyll derivatives for the treatment of sars-cov-2 infection Download PDFInfo
- Publication number
- CA3215826A1 CA3215826A1 CA3215826A CA3215826A CA3215826A1 CA 3215826 A1 CA3215826 A1 CA 3215826A1 CA 3215826 A CA3215826 A CA 3215826A CA 3215826 A CA3215826 A CA 3215826A CA 3215826 A1 CA3215826 A1 CA 3215826A1
- Authority
- CA
- Canada
- Prior art keywords
- pheophorbide
- analog
- acceptable salt
- pharmaceutically acceptable
- sars
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163201568P | 2021-05-05 | 2021-05-05 | |
| US63/201,568 | 2021-05-05 | ||
| PCT/CA2022/050697 WO2022232930A1 (en) | 2021-05-05 | 2022-05-04 | Use of chlorophyll derivatives for the treatment of sars-cov-2 infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3215826A1 true CA3215826A1 (en) | 2022-11-10 |
Family
ID=83931896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3215826A Pending CA3215826A1 (en) | 2021-05-05 | 2022-05-04 | Use of chlorophyll derivatives for the treatment of sars-cov-2 infection |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240366564A1 (https=) |
| EP (1) | EP4333839A4 (https=) |
| JP (1) | JP2024516712A (https=) |
| CA (1) | CA3215826A1 (https=) |
| WO (1) | WO2022232930A1 (https=) |
-
2022
- 2022-05-04 CA CA3215826A patent/CA3215826A1/en active Pending
- 2022-05-04 EP EP22798469.7A patent/EP4333839A4/en active Pending
- 2022-05-04 US US18/558,411 patent/US20240366564A1/en active Pending
- 2022-05-04 WO PCT/CA2022/050697 patent/WO2022232930A1/en not_active Ceased
- 2022-05-04 JP JP2023568213A patent/JP2024516712A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240366564A1 (en) | 2024-11-07 |
| WO2022232930A1 (en) | 2022-11-10 |
| EP4333839A1 (en) | 2024-03-13 |
| JP2024516712A (ja) | 2024-04-16 |
| EP4333839A4 (en) | 2025-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008523153A (ja) | 疾病の伝染を減少させる組成物及び方法 | |
| US20150166476A1 (en) | Methods for treating neurodegenerative diseases associated with aggregation of amyloid-beta | |
| CN105636589B (zh) | 脱氧野尻霉素衍生物及其使用方法 | |
| CA2721040C (en) | Procyanidin extracts of cinnamon, litchi and arachis useful in the treatment of retroviral infections | |
| US11419847B2 (en) | Pharmaceutical micronutrient composition and its use to simultaneously inhibit multiple cellular mechanisms of infectivity caused by coronavirus, its variants and mutants | |
| Azarkar et al. | Curcumin as a natural potential drug candidate against important zoonotic viruses and prions: A narrative review | |
| Hao et al. | Kaempferol is a novel antiviral agent against channel catfish virus infection through blocking viral attachment and penetration in vitro | |
| US20240366564A1 (en) | Use of Chlorophyll Derivatives for the Treatment of SARS-CoV-2 Infection | |
| US9221874B2 (en) | Antiviral peptides against influenza virus | |
| US20240100047A1 (en) | Composition and method for treating covid-19 | |
| US8530525B2 (en) | Methods and compositions for protecting and treating neuroinjury | |
| RU2444363C2 (ru) | Противовирусное средство для профилактики и лечения клещевого энцефалита | |
| CN116942733A (zh) | 一种草药萃取物用于制备抑制个体感染新型冠状病毒的医药组合物的用途 | |
| Ben-Azu et al. | Amelioration of Chronic Unpredictable Mild Stress-Induced Behavioural Perturbations by Noni Juice in Mice: Possible Involvement of Antioxidant System | |
| EP4238560B1 (en) | Therapeutic agent for covid-19 | |
| US20240307487A1 (en) | Compositions of anti-viral peptides and/or compounds and methods of use thereof | |
| US20160243182A1 (en) | Use of cissampelos pareira extracts for treating dengue | |
| WO2022232337A2 (en) | Composition and method for treating covid-19 | |
| EA050727B1 (ru) | Антивирусный препарат микробного происхождения, обладающий активностью в отношении вирусов гриппа и коронавирусов | |
| WO2022248564A1 (en) | Compositions for treating sars-cov2 infection | |
| WO2022123513A1 (en) | Composition and method for managing coronavirus infection | |
| AU2023292051A1 (en) | Compositions and methods for radioprotectant/radiomitigation hybrid and/or decorporation | |
| KR20170039456A (ko) | 오동나무로부터 추출한 ｃ-제라닐플라보노이드계 물질을 포함하는 인플루엔자 예방 및 치료용 약학 조성물 | |
| HK1226942B (en) | Deoxynojirimycin derivatives and methods of their using |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - SMALL Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250328 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250328 |